AHSG and calcification: This paves the road to generate a range of serum biomarkers, in conjunction with fetuin-A, that may be used to identify valvular calcification, the staging of valvular calcification, and progression in patients with aortic stenosis or sclerosis, which could supplement the current standard of cardiac imaging.